| Market Capitalization (Millions $) |
29 |
| Shares
Outstanding (Millions) |
18 |
| Employees |
64 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-51 |
| Cash Flow (TTM) (Millions $) |
-40 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Talis Biomedical Corporation is a molecular diagnostics company that specializes in developing innovative and portable diagnostic solutions. The company's goal is to make accurate and timely diagnostics accessible to healthcare professionals, enabling them to provide better patient care.
Talis Biomedical is known for its Talis One™ system, a molecular diagnostic platform that can rapidly detect and identify infectious diseases with high accuracy. The system uses a combination of innovative technologies, including microfluidics and molecular biology, to automate the diagnostic process and deliver reliable results in a short amount of time.
The company's diagnostic solutions target a wide range of diseases, including respiratory infections, sexually transmitted infections, and other infectious diseases. By providing precise and actionable information, Talis Biomedical aims to help healthcare providers make informed decisions about patient care and improve treatment outcomes.
Talis Biomedical is committed to advancing the field of molecular diagnostics through continuous innovation and research. The company collaborates with leading academic institutions, technology partners, and healthcare organizations to develop cutting-edge diagnostic tools that address unmet needs in the field of healthcare.
Overall, Talis Biomedical Corporation is a pioneering molecular diagnostics company that is focused on revolutionizing the way infectious diseases are diagnosed and treated, with the intention of enhancing healthcare outcomes for patients worldwide.
Company Address: 1375 West Fulton Market Chicago 60607 IL
Company Phone Number: 433-3000 Stock Exchange / Ticker: NASDAQ TLIS
|
0.000%
3.76%